Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery
Journal of Cell Science · 2025
DOI: 10.1242/jcs.264190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Shefali Tripathi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India. Hauptthemen laut MEDLINE: Microtubules, Endosomes, Dependovirus, Gene Transfer Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, DBT-Wellcome Trust India Alliance, Council of Scientific and Industrial Research.
Abstract (Originalsprache)
Adeno-associated virus (AAV) is a widely used vector for gene delivery, yet the host intracellular trafficking barriers often limit its therapeutic efficacy. Here, we identify microtubule detyrosination – a microtubule post-translational modification – as a key regulator of AAV2 endo-lysosomal processing. Using super-resolution microscopy (SIM/STORM), we show that upon AAV2 endocytosis, the host upregulates microtubule detyrosination via the GSK3β–CLASP2 signaling axis. Single-particle tracking of recombinant virus reveals that detyrosinated microtubules form a physical and functional barrier, restricting AAV2 motility and promoting lysosomal trapping. Restoring microtubule tyrosination via tubulin-tyrosine ligase overexpression or pharmacological inhibition of detyrosination with parthenolide, enhances endosomal escape and perinuclear accumulation of AAV2, translating to improved gene delivery in host cells. Notably, a clinically relevant pro-drug of parthenolide (DMAPT) also displayed a similar trend of enhancing AAV2-driven coagulation factor IX expression in hemophilia B mouse models. Our findings uncover a host mechanism that reshapes the microtubule landscape to restrict AAV2 trafficking and identify microtubule detyrosination as a novel druggable target to improve AAV-based gene therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dept of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.
- Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur 208016, India.
- Laurus Centre for Gene Therapy, Indian Institute of Technology Kanpur, Kanpur 208016, India.
- Dept of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India.
ORCID-Profile: Nitin Mohan
Förderung
- Indian Council of Medical Research
- DBT-Wellcome Trust India Alliance
- Council of Scientific and Industrial Research
- Wellcome Trust
- Indian Institute of Technology Kanpur
Zitieren
APA
Tripathi, S., Huda, S., Kar, J., Chandra, D., Jayandharan, G. R., & Mohan, N. (2025). Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery. Journal of Cell Science. https://doi.org/10.1242/jcs.264190
Vancouver
Tripathi S, Huda S, Kar J, Chandra D, Jayandharan GR, Mohan N. Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery. Journal of Cell Science. 2025. doi:10.1242/jcs.264190
BibTeX
@article{Tripathi2025,
author = {Tripathi, Shefali and Huda, Shamshul and Kar, Joydipta and Chandra, Dinesh and Jayandharan, Giridhara R and Mohan, Nitin},
title = {Suppressing microtubule detyrosination augments adeno-associated virus 2 endosomal escape and gene delivery},
journal = {Journal of Cell Science},
year = {2025},
doi = {10.1242/jcs.264190}
}
EUVIMED